Richard D. Boyce
Orcid: 0000-0002-2993-2085
According to our database1,
Richard D. Boyce
authored at least 55 papers
between 2003 and 2023.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2023
Causal feature selection using a knowledge graph combining structured knowledge from the biomedical literature and ontologies: A use case studying depression as a risk factor for Alzheimer's disease.
J. Biomed. Informatics, June, 2023
J. Biomed. Informatics, April, 2023
npj Digit. Medicine, 2023
2022
J. Am. Medical Informatics Assoc., 2022
Coordinated use of Health Level 7 standards to support clinical decision support: Case study with shared decision making and drug-drug interactions.
Int. J. Medical Informatics, 2022
Developing a Knowledge Graph Framework for Pharmacokinetic Natural Product-Drug Interactions.
CoRR, 2022
CoRR, 2022
Evaluation of Shared Decision-Making for Concomitant Warfarin and NSAID Medications using the DDInteract App.
Proceedings of the AMIA 2022, 2022
Developing and Evaluation of Computational Phenotypes of Metastatic Breast Cancer Using All of Us Data.
Proceedings of the AMIA 2022, 2022
Standardizing Natural Products in Adverse Event Reports with Siamese Recurrent Networks.
Proceedings of the AMIA 2022, 2022
2021
Using computable knowledge mined from the literature to elucidate confounders for EHR-based pharmacovigilance.
J. Biomed. Informatics, 2021
Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review.
Proceedings of the MEDINFO 2021: One World, One Health - Global Partnership for Digital Innovation, 2021
2020
Testing the face validity and inter-rater agreement of a simple approach to drug-drug interaction evidence assessment.
J. Biomed. Informatics, 2020
Proceedings of the AMIA 2020, 2020
Automatically classifying the evidence type of drug-drug interaction research papers as a step toward computer supported evidence curation.
Proceedings of the AMIA 2020, 2020
2019
Open Source Software Sustainability Models: Initial White Paper from the Information Technology for Cancer Research Sustainability and Industry Partnership Work Group.
CoRR, 2019
Implementation of Clinical Decision Support Services to Detect Potential Drug-Drug Interaction Using Clinical Quality Language.
Proceedings of the MEDINFO 2019: Health and Wellbeing e-Networks for All, 2019
A Proposal for Determining the Evidence Types of Biomedical Documents Using a Drug-drug Interaction Ontology and Machine Learning.
Proceedings of the AAAI 2019 Spring Symposium on Combining Machine Learning with Knowledge Engineering (AAAI-MAKE 2019) Stanford University, 2019
2018
Extending the DIDEO ontology to include entities from the natural product drug interaction domain of discourse.
J. Biomed. Semant., 2018
Proceedings of the 2018 Text Analysis Conference, 2018
Adverse Reactions and Drug-Drug Interaction Extraction tracks at the Text Analysis Conference (TAC).
Proceedings of the AMIA 2018, 2018
Developing User Personas to Aid in the Design of a User-Centered Natural Product-Drug Interaction Information Resource for Researchers.
Proceedings of the AMIA 2018, 2018
2017
IEEE Trans. Biomed. Circuits Syst., 2017
Information needs for making clinical recommendations about potential drug-drug interactions: a synthesis of literature review and interviews.
BMC Medical Informatics Decis. Mak., 2017
J. Biomed. Informatics, 2017
J. Am. Medical Informatics Assoc., 2017
Large-scale adverse effects related to treatment evidence standardization (LAERTES): an open scalable system for linking pharmacovigilance evidence sources with clinical data.
J. Biomed. Semant., 2017
Automated Screening of Emergency Department Notes for Drug-Associated Bleeding Adverse Events Occurring in Older Adults.
Appl. Clin. Inform., 2017
Formalizing Evidence Type Definitions for Drug-Drug Interaction Studies to Improve Evidence Base Curation.
Proceedings of the MEDINFO 2017: Precision Healthcare through Informatics, 2017
Proceedings of the Summit on Clinical Research Informatics, 2017
Proceedings of the Summit on Clinical Research Informatics, 2017
Toward a reliable and interoperable public repository for natural product drug interaction study data.
Proceedings of the AMIA 2017, 2017
2016
Bringing clinical pharmacogenomics information to pharmacists: A qualitative study of information needs and resource requirements.
Int. J. Medical Informatics, 2016
Proceedings of the Joint International Conference on Biological Ontology and BioCreative, 2016
2015
Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.
BMC Medical Informatics Decis. Mak., 2015
Toward a complete dataset of drug-drug interaction information from publicly available sources.
J. Biomed. Informatics, 2015
Proceedings of International Workshop on Biomedical Data Mining, 2015
OHDSI: An Open-Source Platform for Observational Data Analytics and Collaborative Research.
Proceedings of the AMIA 2015, 2015
2014
Using the Micropublications Ontology and the Open Annotation Data Model to Represent Evidence within a Drug-Drug Interaction Knowledge Base.
Proceedings of the 4th Workshop on Linked Science 2014, 2014
Proceedings of the IEEE Biomedical Circuits and Systems Conference, 2014
2013
Dynamic enhancement of drug product labels to support drug safety, efficacy, and effectiveness.
J. Biomed. Semant., 2013
UWM-TRIADS: Classifying Drug-Drug Interactions with Two-Stage SVM and Post-Processing.
Proceedings of the 7th International Workshop on Semantic Evaluation, 2013
An RDF/OWL Knowledge Base for Query Answering and Decision Support in Clinical Pharmacogenetics.
Proceedings of the MEDINFO 2013, 2013
2012
Emerging practices for mapping and linking life sciences data using RDF - A case series.
J. Web Semant., 2012
Using Natural Language Processing to Extract Drug-Drug Interaction Information from Package Inserts.
Proceedings of the 2012 Workshop on Biomedical Natural Language Processing, 2012
The Influence of Drug Terminologies on the Performance of the NCBO Annotator When Used to Identify Drug Entities in Drug Product Labels.
Proceedings of the AMIA 2012, 2012
2010
Leveraging the semantic web and natural language processing to enhance drug-mechanism knowledge in drug product labels.
Proceedings of the ACM International Health Informatics Symposium, 2010
2009
iCODEHOP: a new interactive program for designing COnsensus-DEgenerate Hybrid Oligonucleotide Primers from multiply aligned protein sequences.
Nucleic Acids Res., 2009
Computing with evidence: Part II: An evidential approach to predicting metabolic drug-drug interactions.
J. Biomed. Informatics, 2009
Computing with evidence: Part I: A drug-mechanism evidence taxonomy oriented toward confidence assignment.
J. Biomed. Informatics, 2009
2007
IEEE Trans. Inf. Technol. Biomed., 2007
2005
2003
Conflation System MBP.
Proceedings of the International Conference on Imaging Science, Systems and Technology, 2003